FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Adam Dicker

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Mouse

Co-author Network

Publications

TOP 3
Quan-Sheng Zhu; K Rosenblatt; K-L Huang; G Lahat; R Brobey; Svetlana V Bolshakov; T Nguyen; Z Ding; R Belousov; K Bill; X Luo; Alexander Lazar; Adam Dicker; Gordon B Mills; Mien-Chie Hung; Dina lev
Vimentin is a novel AKT1 target mediating motility and invasion.
Wendy A Woodward; Robert G Bristow; Michael F Clarke; Robert P Coppes; Massimo Cristofanilli; Dan G Duda; John R Fike; Dolares Hambardzumyan; Richard P Hill; Craig T Jordan; Luka Milas; Frank Pajonk; Walter Curran; Adam Dicker; Yuhchyau Chen
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
Joanne B Weidhaas; Shu-Xia Li; Kathryn Winter; Janice Ryu; Anuja Jhingran; Bridgette Miller; Adam Dicker; David Gaffney
Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Adam Dicker (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Quan-Sheng Zhu; K Rosenblatt; K-L Huang; G Lahat; R Brobey; Svetlana V Bolshakov; T Nguyen; Z Ding; R Belousov; K Bill; X Luo; Alexander Lazar; Adam Dicker; Gordon B Mills; Mien-Chie Hung; Dina lev
Vimentin is a novel AKT1 target mediating motility and invasion.
Oncogene 2011;30(4):457-70.
2009: Wendy A Woodward; Robert G Bristow; Michael F Clarke; Robert P Coppes; Massimo Cristofanilli; Dan G Duda; John R Fike; Dolares Hambardzumyan; Richard P Hill; Craig T Jordan; Luka Milas; Frank Pajonk; Walter Curran; Adam Dicker; Yuhchyau Chen
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
International journal of radiation oncology, biology, physics 2009;74(5):1580-91.
2009: Joanne B Weidhaas; Shu-Xia Li; Kathryn Winter; Janice Ryu; Anuja Jhingran; Bridgette Miller; Adam Dicker; David Gaffney
Changes in gene expression predicting local control in cervical cancer: results from Radiation Therapy Oncology Group 0128.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(12):4199-206.
2009: Mark L Pe; Edouard J Trabulsi; Ramalinga Kedika; Ed Pequignot; Adam Dicker; Leonard G Gomella; Richard Valicenti
Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT.
Urology 2009;73(6):1328-34.
2009: Gregory J Kubicek; Maria Werner-Wasik; Mitchell Machtay; Gayle Mallon; Thomas Myers; Michael Ramirez; David Andrews; Walter Curran; Adam Dicker
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
International journal of radiation oncology, biology, physics 2009;74(2):433-9.
2009: Robert A Linden; Perry R Weiner; Leonard G Gomella; Adam Dicker; David B Suh; Edouard J Trabulsi; Richard Valicenti
Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy.
Urology 2009;73(4):881-6.
2009: James Farrell; Hany Elsaleh; Miguel Garcia; Raymond Lai; Ali Ammar; William F Regine; Ross Abrams; A Bowen Benson; John Macdonald; Carol E Cass; Adam Dicker; John R Mackey
Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.
Gastroenterology 2009;136(1):187-95.
2009: Serra Kamer; Qing Ren; Adam Dicker
Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
Archives of gynecology and obstetrics 2009;279(1):41-6.
2008: Yaacov Richard Lawrence; Maria Werner-Wasik; Adam Dicker
Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.
Future oncology (London, England) 2008;4(5):689-704.
2008: William Davidson; Qing Ren; Gabor Kari; Ori Kashi; Adam Dicker; Ulrich Rodeck
Inhibition of p73 function by Pifithrin-alpha as revealed by studies in zebrafish embryos.
Cell cycle (Georgetown, Tex.) 2008;7(9):1224-30.
2008: Yaacov Richard Lawrence; Adam Dicker
Hypoxia in prostate cancer: observation to intervention.
The lancet oncology 2008;9(4):308-9.
2008: Timothy N Showalter; A Omer Nawaz; Frederick M Fellin; Pramila Rani Anne; Ernest L Rosato; Adam Dicker
Distinguishing post-treatment changes from recurrent disease in cholangiocarcinoma: a case report.
Journal of medical case reports 2008;2():76.
2007: Li-Yan Khor; Kyounghwa Bae; Alan Pollack; M Elizabeth H Hammond; David Grignon; Varagur Venkatesan; Seth A Rosenthal; Mark A Ritter; Howard M Sandler; Gerald E Hanks; William U Shipley; Adam Dicker
COX-2 expression predicts prostate-cancer outcome: analysis of data from the RTOG 92-02 trial.
The lancet oncology 2007;8(10):912-20.
2007: David K Gaffney; Kathryn Winter; Adam Dicker; Brigitte Miller; Patricia J Eifel; Janice Ryu; Vilija Avizonis; Mitch Fromm; William Small; Kathryn Greven
Efficacy and patterns of failure for locally advanced cancer of the cervix treated with celebrex (celecoxib) and chemoradiotherapy in RTOG 0128.
International journal of radiation oncology, biology, physics 2007;69(1):111-7.
2007: Gabor Kari; Ulrich Rodeck; Adam Dicker
Zebrafish: an emerging model system for human disease and drug discovery.
Clinical pharmacology and therapeutics 2007;82(1):70-80.
2007: Kang-Il Kim; Gregg R Klein; Joshua Sleeper; Adam Dicker; Richard H Rothman; Javad Parvizi
Uncemented total hip arthroplasty in patients with a history of pelvic irradiation for prostate cancer.
The Journal of bone and joint surgery. American volume 2007;89(4):798-805.
2007: Phyllis R Wachsberger; Randy Burd; Chris Cardi; Mathew Thakur; Constantine Daskalakis; Jocelyn Holash; George D Yancopoulos; Adam Dicker
VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.
International journal of radiation oncology, biology, physics 2007;67(5):1526-37.
2007: Christine H Chung; Stuart Wong; K. Kian Ang; Elizabeth H Hammond; Adam Dicker; Paul M Harari; Quynh-Thu Le
Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.
International journal of radiation oncology, biology, physics 2007;69(2 Suppl):S67-78.
2007: Christine H Chung; Joel Parker; Shawn Levy; Robbert J C Slebos; Adam Dicker; Ulrich Rodeck
Gene expression profiles as markers of aggressive disease-EGFR as a factor.
International journal of radiation oncology, biology, physics 2007;69(2 Suppl):S102-5.
2007: David K Gaffney; Kathryn Winter; Adam Dicker; Brigitte Miller; Patricia J Eifel; Janice Ryu; Vilija Avizonis; Mitch Fromm; Kathryn Greven
A Phase II study of acute toxicity for Celebrex (celecoxib) and chemoradiation in patients with locally advanced cervical cancer: primary endpoint analysis of RTOG 0128.
International journal of radiation oncology, biology, physics 2007;67(1):104-9.
2006: Borbala Daroczi; Gabor Kari; Mary Frances McAleer; Jeffrey C Wolf; Ulrich Rodeck; Adam Dicker
In vivo radioprotection by the fullerene nanoparticle DF-1 as assessed in a zebrafish model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(23):7086-91.
2006: Mary Frances McAleer; Kevin Duffy; William R Davidson; Gabor Kari; Adam Dicker; Ulrich Rodeck; Eric Wickstrom
Antisense inhibition of cyclin D1 expression is equivalent to flavopiridol for radiosensitization of zebrafish embryos.
International journal of radiation oncology, biology, physics 2006;66(2):546-51.
2006: Qing Ren; Csaba Kari; Marlene R D Quadros; Randy Burd; Peter McCue; Adam Dicker; Ulrich Rodeck
Malignant transformation of immortalized HaCaT keratinocytes through deregulated nuclear factor kappaB signaling.
Cancer research 2006;66(10):5209-15.
2005: Adam Dicker; Ulrich Rodeck
Predicting the future from trials of the past: epidermal growth factor receptor expression and outcome of fractionated radiation therapy trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5437-9.
2005: Qing Ren; Ronghua Liu; Adam Dicker; Ya Wang
CHK1 affects cell sensitivity to microtubule-targeted drugs.
Journal of cellular physiology 2005;203(1):273-6.
2005: Baocheng Hu; Shuang-Yin Han; Xiang Wang; Michelle Ottey; Magdalena B Potoczek; Adam Dicker; Kay Huebner; Ya Wang
Involvement of the Fhit gene in the ionizing radiation-activated ATR/CHK1 pathway.
Journal of cellular physiology 2005;202(2):518-23.
2005: Phyllis R Wachsberger; Randy Burd; Nichol Marero; Constantine Daskalakis; Anderson Ryan; Peter McCue; Adam Dicker
Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):835-42.
2005: Dietmar W Siemann; Michael C Bibby; Graham G Dark; Adam Dicker; Ferry A L M Eskens; Michael R Horsman; Dieter Marmé; Patricia M LoRusso
Differentiation and definition of vascular-targeted therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):416-20.
2005: Kevin Duffy; Mary Frances McAleer; William R Davidson; Laszlo Kari; Csaba Kari; Chang-gong liu; Steven A Farber; Keith C Cheng; Jason R Mest; Eric Wickstrom; Adam Dicker; Ulrich Rodeck
Coordinate control of cell cycle regulatory genes in zebrafish development tested by cyclin D1 knockdown with morpholino phosphorodiamidates and hydroxyprolyl-phosphono peptide nucleic acids.
Nucleic acids research 2005;33(15):4914-21.
2005: Lesley Hughes; Frank M Waterman; Adam Dicker
Salvage of suboptimal prostate seed implantation: Reimplantation of underdosed region of prostate base.
Brachytherapy 2005;4(2):163-70.
2005: C Katzen; Merrill J Solan; Adam Dicker
E-mail and oncology: a survey of radiation oncology patients and their attitudes to a new generation of health communication.
Prostate cancer and prostatic diseases 2005;8(2):189-93.
2005: W A Woodward; Phyllis R Wachsberger; R Burd; Adam Dicker
Effects of androgen suppression and radiation on prostate cancer suggest a role for angiogenesis blockade.
Prostate cancer and prostatic diseases 2005;8(2):127-32.
2005: Mary Frances McAleer; Christian Davidson; William R Davidson; Brad Yentzer; Steven A Farber; Ulrich Rodeck; Adam Dicker
Novel use of zebrafish as a vertebrate model to screen radiation protectors and sensitizers.
International journal of radiation oncology, biology, physics 2005;61(1):10-3.
2004: Phyllis R Wachsberger; Randy Burd; Adam Dicker
Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways.
Hematology/oncology clinics of North America 2004;18(5):1039-57, viii.
2004: Tracy L McElveen; Frank M Waterman; Hayeon Kim; Adam Dicker
Factors predicting for urinary incontinence after prostate brachytherapy.
International journal of radiation oncology, biology, physics 2004;59(5):1395-404.
2004: Gary J Kelloff; Donald S Coffey; Bruce A Chabner; Adam Dicker; Kathryn Z Guyton; Perry D Nisen; Howard R Soule; Anthony V D'Amico
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3927-33.
2004: George Vande Woude; Gary J Kelloff; Raymond W Ruddon; Han-Mo Koo; Caroline C Sigman; J Carl Barrett; Robert W Day; Adam Dicker; Robert S Kerbel; David R Parkinson; William J Slichenmyer
Reanalysis of cancer drugs: old drugs, new tricks.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3897-907.
2004: Susan Lanza-Jacoby; Adam Dicker; Sheldon Miller; Francis E Rosato; John T Flynn; Stephanie N Lavorgna; Randy Burd
Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice.
Molecular cancer therapeutics 2004;3(4):417-24.
2004: Flemming Forsberg; Raymond Ro; Magdalena B Potoczek; Ji-Bin Liu; Christopher R B Merritt; K M James; Adam Dicker; Levon N Nazarian
Assessment of angiogenesis: implications for ultrasound imaging.
Ultrasonics 2004;42(1-9):325-30.
2004: Adam Dicker; Ulrich Rodeck
Targeting the EGFR in neoplasia--more questions than answers.
International journal of radiation oncology, biology, physics 2004;58(3):899-902.
2003: Frank M Waterman; Adam Dicker
Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?
International journal of radiation oncology, biology, physics 2003;57(1):293-9.
2003: Chang-Ching Debbie Lin; Lawrence C Kenyon; Terry Hyslop; Elizabeth Hammond; David W Andrews; Walter Curran; Adam Dicker
Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade.
American journal of clinical oncology 2003;26(4):S98-102.
2003: Courtnay W Bloomer; Lawrence C Kenyon; Elizabeth Hammond; Terry Hyslop; David W Andrews; Walter Curran; Adam Dicker
Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas.
American journal of clinical oncology 2003;26(4):S75-80.
2003: Adam Dicker
COX-2 inhibitors and cancer therapeutics: potential roles for inhibitors of COX-2 in combination with cytotoxic therapy: reports from a symposium held in conjunction with the Radiation Therapy Oncology Group June 2001 Meeting.
American journal of clinical oncology 2003;26(4):S46-7.
2003: Adam Dicker; Torian L Williams; George Iliakis; Derrick S Grant
Targeting angiogenic processes by combination low-dose paclitaxel and radiation therapy.
American journal of clinical oncology 2003;26(3):e45-53.
2003: Phyllis R Wachsberger; Randy Burd; Adam Dicker
Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):1957-71.
2003: Derrick S Grant; Torian L Williams; Michael Zahaczewsky; Adam Dicker
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere).
International journal of cancer. Journal international du cancer 2003;104(1):121-9.
2003: Frank M Waterman; Adam Dicker
Probability of late rectal morbidity in 125I prostate brachytherapy.
International journal of radiation oncology, biology, physics 2003;55(2):342-53.
2003: Ashish B Patel; Frank M Waterman; Adam Dicker
A detailed examination of the difference between planned and treated margins in 125I permanent prostate brachytherapy.
Brachytherapy 2003;2(4):223-8.
2003: Adam Dicker
The safety and tolerability of low-dose irradiation for the management of gynaecomastia caused by antiandrogen monotherapy.
The lancet oncology 2003;4(1):30-6.
2002: Frank M Waterman; Adam Dicker
Impact of postimplant edema on V(100) and D(90) in prostate brachytherapy: can implant quality be predicted on day 0?
International journal of radiation oncology, biology, physics 2002;53(3):610-21.
2002: Flemming Forsberg; Adam Dicker; Mathew L Thakur; Nandkumar M Rawool; Ji-Bin Liu; William Shi; Levon N Nazarian
Comparing contrast-enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: preliminary results.
Ultrasound in medicine & biology 2002;28(4):445-51.
2001: D Butzbach; Frank M Waterman; Adam Dicker
Can extraprostatic extension be treated by prostate brachytherapy? An analysis based on postimplant dosimetry.
International journal of radiation oncology, biology, physics 2001;51(5):1196-9.
2001: Joseph M Kaminski; Robert J Kaminski; Adam Dicker; J L Urbain
Defining a future role for radiogenic therapy.
Cancer treatment reviews 2001;27(5):289-94.
2001: David K Gaffney; Joseph Holden; Karen Zempolich; K J Murphy; Adam Dicker; Mark K Dodson
Elevated COX-2 expression in cervical carcinoma: reduced cause-specific survival and pelvic control.
American journal of clinical oncology 2001;24(5):443-6.
2001: Adam Dicker; Torian L Williams; Derrick S Grant
Targeting angiogenic processes by combination rofecoxib and ionizing radiation.
American journal of clinical oncology 2001;24(5):438-42.
2001: C T Chen; Richard Valicenti; J Lu; T Derose; Adam Dicker; Stephen E Strup; SG Mulholland; Irvin H Hirsch; David E McGinnis; Leonard G Gomella
Does hormonal therapy influence sexual function in men receiving 3D conformal radiation therapy for prostate cancer?
International journal of radiation oncology, biology, physics 2001;50(3):591-5.
2001: Dusica Cvetkovic; Benjamin Movsas; Adam Dicker; Alexandra L Hanlon; Richard E Greenberg; J Donald Chapman; Gerald E Hanks; JV Tricoli
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer.
Urology 2001;57(4):821-5.
2001: C T Chen; Frank M Waterman; Richard Valicenti; L G Gomella; Stephen E Strup; Adam Dicker
Dosimetric analysis of urinary morbidity following prostate brachytherapy (125I vs. 103Pd) combined with external beam radiation therapy.
International journal of cancer. Journal international du cancer 2001;96 Suppl():83-8.
2000: Richard Valicenti; Leonard G Gomella; EA El-Gabry; R Myers; FE Nathan; Stephen E Strup; Adam Dicker; David E McGinnis; G Cardi; M Baltish; M Simirgliano; A Vizzard; SG Mulholland
The multidisciplinary clinic approach to prostate cancer counseling and treatment.
Seminars in urologic oncology 2000;18(3):188-91.
2000: Frank M Waterman; Adam Dicker
The impact of postimplant edema on the urethral dose in prostate brachytherapy.
International journal of radiation oncology, biology, physics 2000;47(3):661-4.
2000: Adam Dicker; A T Figura; Frank M Waterman; Richard Valicenti; Stephen E Strup; Leonard G Gomella
Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?
Techniques in urology 2000;6(2):104-8.
2000: PD Maguire; Frank M Waterman; Adam Dicker
Can the cost of permanent prostate implants be reduced? An argument for peripheral loading with higher strength seeds.
Techniques in urology 2000;6(2):85-8.
2000: Adam Dicker; C C Lin; Dennis B Leeper; Frank M Waterman
Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
Seminars in urologic oncology 2000;18(2):152-9.
2000: Frank M Waterman; Adam Dicker
Determination of the urethral dose in prostate brachytherapy when the urethra cannot be visualized in the postimplant CT scan.
Medical physics 2000;27(3):448-51.
1999: Ning J Yue; Zhe Chen; Richard E Peschel; Adam Dicker; Frank M Waterman; Ravinder Nath
Optimum timing for image-based dose evaluation of 125I and 103PD prostate seed implants.
International journal of radiation oncology, biology, physics 1999;45(4):1063-72.
1999: Frank M Waterman; Adam Dicker
Effect of post-implant edema on the rectal dose in prostate brachytherapy.
International journal of radiation oncology, biology, physics 1999;45(3):571-6.
1999: Richard Valicenti; Leonard G Gomella; M Ismail; Stephen E Strup; SG Mulholland; Adam Dicker; RO Petersen; C J Newschaffer
The efficacy of early adjuvant radiation therapy for pT3N0 prostate cancer: a matched-pair analysis.
International journal of radiation oncology, biology, physics 1999;45(1):53-8.
1999: Richard Valicenti; J W Sweet; W W Hauck; Richard S Hudes; T Lee; Adam Dicker; Frank M Waterman; Pramila Rani Anne; BW Corn; James M Galvin
Variation of clinical target volume definition in three-dimensional conformal radiation therapy for prostate cancer.
International journal of radiation oncology, biology, physics 1999;44(4):931-5.
1999: Ning J Yue; Adam Dicker; Ravinder Nath; Frank M Waterman
The impact of edema on planning 125I and 103Pd prostate implants.
Medical physics 1999;26(5):763-7.
1999: Ning J Yue; Adam Dicker; BW Corn; Ravinder Nath; Frank M Waterman
A dynamic model for the estimation of optimum timing of computed tomography scan for dose evaluation of 125I or 103Pd seed implant of prostate.
International journal of radiation oncology, biology, physics 1999;43(2):447-54.
1998: Frank M Waterman; Ning J Yue; BW Corn; Adam Dicker
Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: an analysis based on serial CT acquisition.
International journal of radiation oncology, biology, physics 1998;41(5):1069-77.
1997: Frank M Waterman; Ning J Yue; S Reisinger; Adam Dicker; BW Corn
Effect of edema on the post-implant dosimetry of an I-125 prostate implant: a case study.
International journal of radiation oncology, biology, physics 1997;38(2):335-9.
1997: Michael J Zelefsky; Laura Happersett; Steven A Leibel; Chandra M Burman; Lawrence H Schwartz; Adam Dicker; Gerald J Kutcher; Zvi Fuks
The effect of treatment positioning on normal tissue dose in patients with prostate cancer treated with three-dimensional conformal radiotherapy.
International journal of radiation oncology, biology, physics 1997;37(1):13-9.
1996: EA Ercikan-Abali; M C Waltham; Adam Dicker; B I Schweitzer; H Gritsman; Debabrata Banerjee; Joseph R Bertino
Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
Molecular pharmacology 1996;49(3):430-7.
1995: Marian B Meyers; Carlotta Zamparelli; Daniela Verzili; Adam Dicker; Thomas J J Blanck; Emilia Chiancone
Calcium-dependent translocation of sorcin to membranes: functional relevance in contractile tissue.
FEBS letters 1995;357(3):230-4.
1993: Adam Dicker; M C Waltham; M Volkenandt; B I Schweitzer; G M Otter; F A Schmid; Francis M Sirotnak; Joseph R Bertino
Methotrexate resistance in an in vivo mouse tumor due to a non-active-site dihydrofolate reductase mutation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(24):11797-801.
1993: R Fanin; Debabrata Banerjee; M Volkenandt; M Waltham; W W Li; Adam Dicker; B I Schweitzer; Joseph R Bertino
Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
Molecular pharmacology 1993;44(1):13-21.
1993: J Steckel; Adam Dicker; M Goldstein
Relationship between varicocele size and response to varicocelectomy.
The Journal of urology 1993;149(4):769-71.
1992: M Goldstein; B R Gilbert; Adam Dicker; J Dwosh; C Gnecco
Microsurgical inguinal varicocelectomy with delivery of the testis: an artery and lymphatic sparing technique.
The Journal of urology 1992;148(6):1808-11.
1992: M Volkenandt; Adam Dicker; Debabrata Banerjee; R Fanin; B Schweitzer; T Horikoshi; Kathleen D Danenberg; Peter V Danenberg; Joseph R Bertino
Quantitation of gene copy number and mRNA using the polymerase chain reaction.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(1):1-6.
1992: Peter V Danenberg; T Horikoshi; M Volkenandt; Kathleen D Danenberg; Heinz-Josef Lenz; L C Shea; Adam Dicker; A Simoneau; Peter A Jones; Joseph R Bertino
Detection of point mutations in human DNA by analysis of RNA conformation polymorphism(s).
Nucleic acids research 1992;20(3):573-9.
1992: Anne-Marie Sapse; B S Schweitzer; Adam Dicker; Joseph R Bertino; V Frecer
Ab initio studies of aromatic-aromatic and aromatic-polar interactions in the binding of substrate and inhibitor to dihydrofolate reductase.
International journal of peptide and protein research 1992;39(1):18-23.
1990: Adam Dicker; M Volkenandt; B I Schweitzer; Debabrata Banerjee; Joseph R Bertino
Identification and characterization of a mutation in the dihydrofolate reductase gene from the methotrexate-resistant Chinese hamster ovary cell line Pro-3 MtxRIII.
The Journal of biological chemistry 1990;265(14):8317-21.
1990: B I Schweitzer; Adam Dicker; Joseph R Bertino
Dihydrofolate reductase as a therapeutic target.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1990;4(8):2441-52.
1990: M Volkenandt; M Löhr; Adam Dicker
[Gene amplification by the polymerase chain reaction].
Deutsche medizinische Wochenschrift (1946) 1990;115(17):670-6.
1990: Adam Dicker; M Volkenandt; A P Albino
Mutational analysis of human NRAS genes in malignant melanoma: rapid methods for oligonucleotide hybridization and manual and automated direct sequencing of products generated by the polymerase chain reaction.
Genes, chromosomes & cancer 1990;1(4):257-69.
1989: Adam Dicker; M Volkenandt; A Adamo; C Barreda; Joseph R Bertino
Sequence analysis of a human gene responsible for drug resistance: a rapid method for manual and automated direct sequencing of products generated by the polymerase chain reaction.
BioTechniques 1989;7(8):830-8.
1989: Adam Dicker; M Volkenandt; Joseph R Bertino
Detection of a single base mutation in the human dihydrofolate reductase gene from a methotrexate-resistant cell line using the polymerase chain reaction.
Cancer communications 1989;1(1):7-12.